Literature DB >> 20936808

Conformational dynamics in human purine nucleoside phosphorylase with reactants and transition-state analogues.

Jennifer S Hirschi1, Karunesh Arora, Charles L Brooks, Vern L Schramm.   

Abstract

Dynamic motions of human purine nucleoside phosphorylase (hPNP) in complex with transition-state analogues and reactants were studied using 10 ns explicit solvent molecular dynamics simulations. hPNP is a homotrimer that catalyzes the phosphorolysis of purine 6-oxynucleosides. The ternary complex of hPNP includes the binding of a ligand and phosphate to the active site. Molecular dynamics simulations were performed on the ternary complex of six ligands including the picomolar transition-state analogues, Immucillin-H (K(d) = 56 pM), DADMe-Immucillin-H (K(d) = 8.5 pM), DATMe-Immucillin-H (K(d) = 8.6 pM), SerMe-Immucillin-H (K(d) = 5.2 pM), the substrate inosine, and a complex containing only phosphate. Protein-inhibitor complexes of the late transition-state inhibitors, DADMe-Imm-H and DATMe-Imm-H, are inflexible. Despite the structural similarity of SerMe-Imm-H and DATMe-Imm-H, the protein complex of SerMe-Imm-H is flexible, and the inhibitor is highly mobile within the active sites. All inhibitors exhibit an increased number of nonbonding interactions in the active site relative to the substrate inosine. Water density within the catalytic site is lower for DADMe-ImmH, DATMe-Imm-H, and SerMe-Imm-H than that for the substrate inosine. Tight binding of the picomolar inhibitors results from increased interactions within the active site and a reduction in the number of water molecules organized within the catalytic site relative to the substrate inosine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20936808      PMCID: PMC3005859          DOI: 10.1021/jp108056s

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  26 in total

1.  Improved treatment of the protein backbone in empirical force fields.

Authors:  Alexander D MacKerell; Michael Feig; Charles L Brooks
Journal:  J Am Chem Soc       Date:  2004-01-28       Impact factor: 15.419

2.  Energetic mapping of transition state analogue interactions with human and Plasmodium falciparum purine nucleoside phosphorylases.

Authors:  Andrzej Lewandowicz; Erika A Taylor Ringia; Li-Min Ting; Kami Kim; Peter C Tyler; Gary B Evans; Olga V Zubkova; Simon Mee; Gavin F Painter; Dirk H Lenz; Richard H Furneaux; Vern L Schramm
Journal:  J Biol Chem       Date:  2005-06-16       Impact factor: 5.157

3.  Transition-state interactions revealed in purine nucleoside phosphorylase by binding isotope effects.

Authors:  Andrew S Murkin; Peter C Tyler; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2008-01-30       Impact factor: 15.419

Review 4.  CHARMM: the biomolecular simulation program.

Authors:  B R Brooks; C L Brooks; A D Mackerell; L Nilsson; R J Petrella; B Roux; Y Won; G Archontis; C Bartels; S Boresch; A Caflisch; L Caves; Q Cui; A R Dinner; M Feig; S Fischer; J Gao; M Hodoscek; W Im; K Kuczera; T Lazaridis; J Ma; V Ovchinnikov; E Paci; R W Pastor; C B Post; J Z Pu; M Schaefer; B Tidor; R M Venable; H L Woodcock; X Wu; W Yang; D M York; M Karplus
Journal:  J Comput Chem       Date:  2009-07-30       Impact factor: 3.376

Review 5.  Binding isotope effects: boon and bane.

Authors:  Vern L Schramm
Journal:  Curr Opin Chem Biol       Date:  2007-09-14       Impact factor: 8.822

6.  Purine nucleoside phosphorylase. 1. Structure-function studies.

Authors:  M D Erion; K Takabayashi; H B Smith; J Kessi; S Wagner; S Hönger; S L Shames; S E Ealick
Journal:  Biochemistry       Date:  1997-09-30       Impact factor: 3.162

7.  Four generations of transition-state analogues for human purine nucleoside phosphorylase.

Authors:  Meng-Chiao Ho; Wuxian Shi; Agnes Rinaldo-Matthis; Peter C Tyler; Gary B Evans; Keith Clinch; Steven C Almo; Vern L Schramm
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

8.  Third-generation immucillins: syntheses and bioactivities of acyclic immucillin inhibitors of human purine nucleoside phosphorylase.

Authors:  Keith Clinch; Gary B Evans; Richard F G Fröhlich; Richard H Furneaux; Peter M Kelly; Laurent Legentil; Andrew S Murkin; Lei Li; Vern L Schramm; Peter C Tyler; Anthony D Woolhouse
Journal:  J Med Chem       Date:  2009-02-26       Impact factor: 7.446

9.  CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields.

Authors:  K Vanommeslaeghe; E Hatcher; C Acharya; S Kundu; S Zhong; J Shim; E Darian; O Guvench; P Lopes; I Vorobyov; A D Mackerell
Journal:  J Comput Chem       Date:  2010-03       Impact factor: 3.376

10.  Loop-tryptophan human purine nucleoside phosphorylase reveals submillisecond protein dynamics.

Authors:  Mahmoud Ghanem; Nickolay Zhadin; Robert Callender; Vern L Schramm
Journal:  Biochemistry       Date:  2009-04-28       Impact factor: 3.162

View more
  17 in total

1.  Density functional study on the derivatives of purine.

Authors:  Chi Wei-Jie; Li Lu-Lin; Li Bu-Tong; Wu Hai-Shun
Journal:  J Mol Model       Date:  2012-08       Impact factor: 1.810

2.  A Biophysical Perspective on Enzyme Catalysis.

Authors:  Pratul K Agarwal
Journal:  Biochemistry       Date:  2018-12-18       Impact factor: 3.162

Review 3.  Enzymatic transition states, transition-state analogs, dynamics, thermodynamics, and lifetimes.

Authors:  Vern L Schramm
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

4.  Transition States and transition state analogue interactions with enzymes.

Authors:  Vern L Schramm
Journal:  Acc Chem Res       Date:  2015-04-07       Impact factor: 22.384

5.  Catalytic site conformations in human PNP by 19F-NMR and crystallography.

Authors:  Javier Suarez; Antti M Haapalainen; Sean M Cahill; Meng-Chiao Ho; Funing Yan; Steven C Almo; Vern L Schramm
Journal:  Chem Biol       Date:  2013-02-21

6.  Modulating Enzyme Catalysis through Mutations Designed to Alter Rapid Protein Dynamics.

Authors:  Ioanna Zoi; Javier Suarez; Dimitri Antoniou; Scott A Cameron; Vern L Schramm; Steven D Schwartz
Journal:  J Am Chem Soc       Date:  2016-03-08       Impact factor: 15.419

7.  Arsenate and phosphate as nucleophiles at the transition states of human purine nucleoside phosphorylase.

Authors:  Rafael G Silva; Jennifer S Hirschi; Mahmoud Ghanem; Andrew S Murkin; Vern L Schramm
Journal:  Biochemistry       Date:  2011-03-10       Impact factor: 3.162

8.  Femtosecond dynamics coupled to chemical barrier crossing in a Born-Oppenheimer enzyme.

Authors:  Rafael G Silva; Andrew S Murkin; Vern L Schramm
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 9.  Transition States, analogues, and drug development.

Authors:  Vern L Schramm
Journal:  ACS Chem Biol       Date:  2013-01-04       Impact factor: 5.100

10.  Conformational freedom in tight binding enzymatic transition-state analogues.

Authors:  Matthew W Motley; Vern L Schramm; Steven D Schwartz
Journal:  J Phys Chem B       Date:  2013-08-08       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.